The Safety, Tolerability, and Effects on the Systemic Inflammatory Response and Renal Function of the Human Chorionic Gonadotropin Hormone-Derivative EA-230 Following On-Pump Cardiac Surgery (The EASI Study): Protocol for a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study

The Safety, Tolerability, and Effects on the Systemic Inflammatory Response and Renal Function of the Human Chorionic Gonadotropin Hormone-Derivative EA-230 Following On-Pump Cardiac Surgery (The EASI Study): Protocol for a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study

Authors of this article:

Roger van Groenendael^{1, 2, 3} ;   Remi Beunders^{1, 2} ;   Jan Hofland³ ;   Wim J Morshuis⁴ ;   Matthijs Kox^{1, 2} ;   Lucas T van Eijk³ ;   Peter Pickkers^{1, 2}